December 1, 2021

Wire Service Canada

Complete Canadian News World

Anti-Corona Pharmacy: The EU Commission is examining the new Covid drug

More hope for corona patients: European Pharmaceuticals (EMA) is exploring the approval of a corona drug from the US pharmaceutical company Merck & Co. Was in charge. The EMA is continuing its investigation into a drug called molnupravir to treat adult Govt-19 patients. Molnupiravir is a pill-based antiviral drug developed in conjunction with MSD (known as Merck & Co. in the United States) and Ridgeback Biotherapies.

Two weeks ago, Merck & Co already applied for emergency approval in the United States. In early October, the company and its partner released the results of a study that halved the risk of hospitalization or life-threatening illness for patients affected by molluscum contagiosum.

READ  With China as the locomotive, it raises the outlook for 2022